XECCAPSMA
Live / Applied — Non-final action written — not yet mailed (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 23 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79442196
- Mark type
- Stylized text
- Filed
- 23 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations; radiopharmaceuticals; radioactive materials for medical purposes; sealed radioactive substances for medical purposes; radioactive elements for medical use; radiological contrast substances for medical purposes; radiopharmaceutical preparations for diagnostic purposes; radioisotope markers for therapeutic or diagnostic use; radiopharmaceuticals for treatment of prostate cancer; radiopharmaceuticals for cancer treatment; radioactive pharmaceuticals; radioactive therapeutic pharmaceuticals; pharmaceutical preparations for treatment of metastatic cancer; nuclear medicine therapeutic preparations; pharmaceutical preparations for cancer treatment; contrast agents for nuclear medicine imaging and therapy; prostate cancer-targeting agents; peptide-based radiolabeled agents for therapeutic or diagnostic use.
Owner
Prosecution history
- 13 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 12 Mar 2026 — NON-FINAL ACTION WRITTEN
- 10 Mar 2026 — ASSIGNED TO EXAMINER
- 01 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 01 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Jan 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB